Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
Yot Teerawattananon, Thunyarat Anothaisintawee, Chatkamol Pheerapanyawaranun, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261930-e0261930
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Cuban Abdala vaccine: Effectiveness in preventing severe disease and death from COVID-19 in Havana, Cuba; A cohort study
Pedro I. Más-Bermejo, Félix O. Dickinson-Meneses, Kenia Almenares-Rodríguez, et al.
The Lancet Regional Health - Americas (2022) Vol. 16, pp. 100366-100366
Open Access | Times Cited: 33
Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco
Jihane Belayachi, Majdouline Obtel, Abdelkader Mhayi, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0278546-e0278546
Open Access | Times Cited: 26
What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection into the Past and A Way Forward
Sarin KC, Lydia Lin, Diana Beatriz Bayani, et al.
International Journal of Health Policy and Management (2023)
Open Access | Times Cited: 9
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic
Yi Wang, Nantasit Luangasanatip, Wirichada Pan‐ngum, et al.
The European Journal of Health Economics (2022) Vol. 24, Iss. 5, pp. 735-748
Open Access | Times Cited: 12
Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: a prospective cohort study
Mingkwan Wichaidit, Tanawin Nopsopon, Krittiyaporn Sunan, et al.
The Lancet Regional Health - Southeast Asia (2022) Vol. 8, pp. 100106-100106
Open Access | Times Cited: 12
Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco
Jihane Belayachi, Majdouline Obtel, Rachid Razıne, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Real-World Effectiveness of the mRNA COVID-19 Vaccines in Japan: A Case–Control Study
Megumi Hara, Takeki Furue, Mami Fukuoka, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 779-779
Open Access | Times Cited: 11
COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)—A Systematic Review of Study Designs and Methods
Malede Mequanent Sisay, Camila Montesinos‐Guevara, Alhadi Khogali Osman, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1035-1035
Open Access | Times Cited: 6
Cuban Abdala Vaccine: Effectiveness in Preventing Severe Disease and Death from COVID-19 in Havana, Cuba; a Cohort Study
Pedro Inocencio Más-Bermejo, Felix Orlando Dickinson-Meneses, Kenia Almenares-Rodríguez, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 10
Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings
Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Immediate and Long-Term Adverse Events of COVID-19 Vaccines: A One-Year Follow-Up Study From the Kurdistan Region of Iraq
Manhal Ahmed Abdulkader, Muayad Aghali Merza
Cureus (2023)
Open Access | Times Cited: 4
Monitoring and Evaluation of National Vaccination Implementation: A Scoping Review of How Frameworks and Indicators Are Used in the Public Health Literature
Manar Marzouk, Maryam Omar, Kanchanok Sirison, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 567-567
Open Access | Times Cited: 7
Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy
Annalisa Fierro, Silvio Romano, Antonella Liccardo
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0265159-e0265159
Open Access | Times Cited: 6
Measuring the efficacy of a vaccine during an epidemic
Antonio Scala, Pierpaolo Cavallo
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0290652-e0290652
Open Access | Times Cited: 3
Is Data Science Transforming Biomedical Research? Evidence, Expertise, and Experiments in COVID-19 Science
Sabina Leonelli
Philosophy of Science (2023), pp. 1-11
Open Access | Times Cited: 3
Outcome and Severity of COVID-19 in Vaccinated and Unvaccinated patients
Syeda Naveera Raza, Santosh Kumar, Ambrina Khatoon, et al.
(2023) Vol. 17, Iss. 6, pp. 89-91
Open Access | Times Cited: 2
Effectiveness of COVID-19 mRNA vaccine in preventing infection against Omicron strain: Findings from the Hiroshima Prefecture COVID-19 version J-SPEED for PCR center
Yui Yumiya, Kenya Kawanishi, Odgerel Chimed‐Ochir, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0003071-e0003071
Open Access
Vaccination and Variants: retrospective model for the evolution of Covid-19 in Italy
Annalisa Fierro, Silvio Romano, Antonella Liccardo
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Evaluation of BNT162b2 vaccine effectiveness in Malaysia: test negative case-control study
Audrey Huili Lim, Norazida Ab Rahman, Su Miin Ong, et al.
Vaccine (2022) Vol. 40, Iss. 39, pp. 5675-5682
Open Access | Times Cited: 3
Biases in COVID-19 vaccine effectiveness studies using cohort design
Suneth Agampodi, Birkneh Tilahun Tadesse, Sushant Sahastrabuddhe, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Capacity-building for conducting COVID-19 vaccine effectiveness studies to enhance evidence-informed vaccination policymaking in the Eastern Mediterranean Region
Mehrnaz Kheirandish, Zahra Karimian, Kamal Fahmy, et al.
Eastern Mediterranean Health Journal (2023) Vol. 29, Iss. 7, pp. 562-569
Open Access | Times Cited: 1
Navigating the Herd Immunity Surface: A Novel Framework for Optimising Epidemic Response Strategies
Gabriele Oliva, Sandro Bonfigli, Pierpaolo Cavallo, et al.
(2023)
Open Access | Times Cited: 1
Preliminary In Vivo Evidence of Oral Selenium Supplementation as a Potentiating Agent on a Vector-Based COVID-19 Vaccine in BALB/c Mice
Muunda Mudenda, Josephine Kimani, Johnson Kinyua, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 57-57
Open Access | Times Cited: 2
Flu vaccination effectiveness in Tabuk City, Saudi Arabia
Rofayda Mansour Ahmed Mohamad, Salem Khalil Adhahi, Intisar Alwadai, et al.
The Egyptian Journal of Hospital Medicine (2023) Vol. 90, Iss. 1, pp. 738-742
Open Access
The Effectiveness of Covid-19 Vaccination in Indonesian Population: A Case-Control Study Protocol
Sri Idaiani, Nurhayati Nurhayati, Delima Delima, et al.
(2023), pp. 785-795
Open Access
Page 1 - Next Page

Scroll to top